ロード中...
Recent trends in the treatment of chronic hepatitis C
Pegylated interferon and ribavirin combination therapy is accepted as the standard antiviral treatment for chronic hepatitis C regardless of HCV genotype. This combination therapy achieves higher response rates than previous therapy, but, nevertheless, a large proportion of patients suffer from trea...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association for the Study of the Liver
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3326995/ https://ncbi.nlm.nih.gov/pubmed/22511899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/kjhep.2012.18.1.22 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|